INOGEN INC

INGN is the ticker for Inogen, Inc., a medical device company that develops, manufactures, and markets portable oxygen concentrators and related respiratory therapy products. The company serves patients, clinicians, and home healthcare providers, primarily in the United States and select international markets. Its products are designed to deliver supplemental oxygen in ambulatory settings, addressing chronic respiratory conditions such as COPD.

The current price of INGN stock fluctuates during market hours based on trading activity. For the most recent quote, please refer to the live price data displayed on this page. That figure reflects the latest trade and may differ from delayed or historical prices.

INGN's recent performance can be assessed by comparing its latest price with prior closes over various periods, such as one week, one month, or year to date. The page displays the latest performance data, including percentage changes, which offer a clearer picture than a single price point. For context, review the historical price chart also shown here.

Valuation for INGN typically involves comparing its market price to financial fundamentals such as revenue, earnings, and cash flow. Common metrics include price-to-sales, price-to-earnings (if applicable), and enterprise value multiples. Because INGN operates in the medical device sector, investors may also consider growth trajectories and margin trends. The page provides relevant valuation ratios to support analysis.

INGN shares may be eligible for extended-hours trading through certain brokers, depending on the exchange and the broker's policies. Pre-market and after-hours sessions allow trading outside the standard 9:30 a.m. to 4:00 p.m. Eastern Time window, but liquidity is often lower and spreads wider. Check with your brokerage for specific availability and any associated risks.

Key risks for INGN include regulatory changes affecting medical device reimbursement, competition from other oxygen therapy providers, supply chain disruptions, and reliance on key distribution partners. The company also faces product development and commercialization risks, as well as potential reimbursement pressure from insurers or government programs. Additionally, broader market and economic conditions can impact its stock price.